Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

August 04, 2015 5:01 AM ET


Company Overview of Alexion Pharmaceuticals, Inc.

Key Executives for Alexion Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
David L. Hallal 10 RelationshipsChief Executive Officer and Director49
Leonard Bell M.D.10 RelationshipsCo-Founder, Chairman of The Board and Consultant57
Joseph A. Madri Ph.D., M.D.No RelationshipsCo-Founder68
Vikas Sinha M.B.A., C.A., CPANo RelationshipsChief Financial Officer and Executive Vice President52
Frank J. Wright No RelationshipsSenior Vice President and President of Alexion Pharma International Sàrl67
View More Key Executives

Alexion Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Leonard Bell M.D. 10 RelationshipsAlexion Pharmaceuticals, Inc.57
David L. Hallal 10 RelationshipsAlexion Pharmaceuticals, Inc.49
R. Douglas Norby 47 RelationshipsMagnaChip Semiconductor Corporation79
Alvin S. Parven 10 RelationshipsAlexion Pharmaceuticals, Inc.75
Andreas Rummelt Ph.D. 24 RelationshipsInterPharmaLink AG59
View All Board Members

Alexion Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee R. Douglas Norby47 Relationships4 Executives
Compensation Committee Alvin S. Parven10 Relationships3 Executives
Nominating Committee J.D.Ann M. Veneman52 Relationships4 Executives
Corporate Governance Committee J.D.Ann M. Veneman52 Relationships4 Executives
Finance Committee R. Douglas Norby47 Relationships4 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Not meaningful
Total Short Term Compensation$48.2M
Not meaningful
Total Value of Options$696.1K
Compensation as of Fiscal Year 2014
Alexion Pharmaceuticals, Inc. CEO Compensation
Industry Average


Aunt Fannies Appoints Barclay Hope as Board of Advisors
July 13, 2015 1:22 PM ET
Anpath Group, Inc. Elects Arthur R. Batson as Chief Executive Officer and President
July 09, 2015 8:43 PM ET
Katy Industries, Inc. Announces Executive and Management Changes
July 08, 2015 5:13 PM ET
Energizer Holdings, Inc. Announces Management Changes
July 07, 2015 12:31 PM ET
Colgate-Palmolive Co. Appoints Mukul Deoras as Global Chief Marketing Officer
July 02, 2015 6:50 AM ET

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Alexion Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at